[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
:: Volume 16, Number 3 (9-2014) ::
2014, 16(3): 175-182 Back to browse issues page
Effects of Standardized Extract of Ginseng (G115) on Biomarkers of Systemic Low-Grade Inflammation in Patients with Type 2 diabetes: A Double-blind Clinical Trial
seyed ahmad hosseini, meysam alipour *, mehrnoosh zakerkish, mohammad hossein haghighizadeh
msc university , seyedahmadhosseini@yahoo.com
Abstract:   (3163 Views)
Introduction:Systemic Inflammation plays a crutal play in the development of cardiovascular disease in patients with Type 2 diabetes. The aim of this study was to investigate the effect of standardized extract of ginseng (G115) in Biomarkers of Systemic Low-Grade Inflammation in patients with Type 2 diabetes. Materials and Methods: This randomized, double-blind trial was performed on 40 patients with type 2 diabetes (28 females and 12 males) were randomly assigned to two groups. Group one were given 300 mg (3×100 mg capsules) standardized extract of ginseng, while group 2 took placebos. After eight weeks, anthropometric indices, glycosylated hemoglobin (HbA1c), interleukin 6 (IL6), tumor necrosis factor (TNFα) and high sensitive C- Reactive Protein (hsCRP) were studied. Results: In the present study, no significant differences were observed in anthropometric indices, glycated hemoglobin and TNFα in the intervention and placebo groups before and after intervention. At the end of the study, a significant reduction was observed in IL6 (8.43± 1.17 vs. 6.79±1.39 ng/L) and hsCRP (3.61±0.49 vs. 3.03±0.33 mg/dL) in the treatment group. Furthermore, there was a significant difference in IL6 (6.79±1.39 vs. 7.85±0.69 ng/L) and hsCRP (3.03±0.33 vs. 3.49±0.39 mg/dL) between the intervention and placebo groups at the end of the study. Conclusions: Administration of standardized ginseng extract for eight weeks caused reductions in IL6 and hsCRP in patients with type 2 diabetes. Therefore, administration of standardized extract of ginseng may play an effective role in the management of these patients.
Keywords: Standardized ginseng extract, Diabetes, Systemic Low-Grade Inflammation
Full-Text [PDF 304 kb]   (870 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2014/01/19 | Accepted: 2014/05/7 | Published: 2014/09/8
Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

hosseini S A, alipour M, zakerkish M, haghighizadeh M H. Effects of Standardized Extract of Ginseng (G115) on Biomarkers of Systemic Low-Grade Inflammation in Patients with Type 2 diabetes: A Double-blind Clinical Trial. Iranian Journal of Endocrinology and Metabolism. 2014; 16 (3) :175-182
URL: http://ijem.sbmu.ac.ir/article-1-1673-en.html
Volume 16, Number 3 (9-2014) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 800 queries by yektaweb 3461